SCHEMBL113398

SCHEMBL113398

CC1CCC(C(C)C)C(OC(=O)OCCO)C1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.51
CYP19A1 P11511 2/20 0.49
ALDH1A1 P00352 8/20 0.47
HPGD P15428 2/20 0.47
MAPT P10636 3/20 0.46
TSHR P16473 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
MAPK1 P28482 1/20 0.44
USP2 O75604 1/20 0.43
LMNA P02545 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
TRPM8 Q7Z2W7 1/20 0.42
APOBEC3A P31941 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12449335 1.00 EPHX1 (0.51) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL906566 1.00 EPHX1 (0.51) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL19865132 1.00 EPHX1 (0.51) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL28260167 1.00 EPHX1 (0.51) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL4660355 0.93 EPHX1 (0.50) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL28880174 0.93 EPHX1 (0.55) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL536647 0.91 EPHX1 (0.48) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL537561 0.91 EPHX1 (0.48) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL20917768 0.90 CYP19A1 (0.45) EPHX1CYP19A1ALDH1A1HPGDMAPT
SCHEMBL6941897 0.89 EPHX1 (0.51) EPHX1CYP19A1ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 899 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034046-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL L'OREAL (FR) 2026-02-05 US claimed
US-20260000602-A1 ANHYDROUS HAIR TREATMENT COMPOSITION L'OREAL (FR) 2026-01-01 US claimed
EP-4442241-A2 RETINOL REPLACEMENT IN SKIN TREATMENT Symrise AG (DE) 2024-10-09 EP claimed
EP-3773445-B1 RETINOL REPLACEMENT IN SKIN TREATMENT SYMRISE AG (DE) 2024-07-24 EP claimed
CN-117813077-A Composition and method for producing the same 西姆莱斯股份公司 2024-04-02 CN claimed
CN-117615798-A Composition for combating malodour 西姆莱斯股份公司 2024-02-27 CN claimed
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES SYMRISE AG (DE) 2024-02-22 US claimed
CN-117481998-A Retinol substitutes in skin treatment 西姆莱斯有限公司 2024-02-02 CN claimed
EP-4259287-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES Symrise AG (DE) 2023-10-18 EP claimed
EP-3081207-B1 USE OF A LIPOSOME COMPOSITION SYMRISE AG (DE) 2022-09-21 EP claimed
US-20100226864-A1 ALKYL-SUBSTITUTED TETRAHYDROPYRANS AS FLAVORING SUBSTANCES SYMRISE GMBH & CO. KG (DE) 2010-09-09 US claimed
EP-2168957-A2 Alkyl-substituted tetrahydropyranes as aromatic materials Symrise GmbH & Co. KG (DE) 2010-03-31 EP claimed
US-20090297468-A1 Mixtures Comprising Anthranilic Acid Amides and Cooling Agents as Cosmetic and Pharmaceutical Compositions for Alleviating Itching SYMRISE GMBH & CO. KG (DE) 2009-12-03 US claimed
US-20090226537-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING SYMRISE GMBH & CO. KG (DE) 2009-09-10 US claimed
WO-2009087242-A2 COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT SYMRISE GMBH & CO. KG (DE) 2009-07-16 WO claimed
EP-1959915-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING Symrise GmbH & Co. KG (DE) 2008-08-27 EP claimed
EP-1893161-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND COOLING AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING Symrise GmbH & Co. KG (DE) 2008-03-05 EP claimed
WO-2007062957-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING SYMRISE GMBH & CO. KG (DE) 2007-06-07 WO claimed
WO-2006134013-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND COOLING AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING SYMRISE GMBH & CO. KG (DE) 2006-12-21 WO claimed
WO-2006134120-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND COOLING AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING SYMRISE GMBH & CO. KG (DE) 2006-12-21 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100226864-A1 ALKYL-SUBSTITUTED TETRAHYDROPYRANS AS FLAVORING SUBSTANCES TAS1R3, TAS2R10, TAS2R50 EPHX1 2547/4885CYP19A1 2489/4885ALDH1A1 69/4885
US-20240058243-A1 A METHOD FOR FIGHTING MICROORGANISMS USING MENTHOL DERIVATIVES MGLL, GCDH, GK EPHX1 1246/4885CYP19A1 2099/4885ALDH1A1 935/4885
US-20260000602-A1 ANHYDROUS HAIR TREATMENT COMPOSITION TAS2R40, BRDT, APOB EPHX1 3502/4885CYP19A1 1460/4885ALDH1A1 1428/4885
US-20260034046-A1 ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL KRT18, DSG1, PRKDC EPHX1 2981/4885CYP19A1 1992/4885ALDH1A1 983/4885
US-20090297468-A1 Mixtures Comprising Anthranilic Acid Amides and Cooling Agents as Cosmetic and Pharmaceutical Compositions for Alleviating Itching H1-0, ASIC1, MCOLN1 EPHX1 2046/4885CYP19A1 81/4885ALDH1A1 418/4885
US-20090226537-A1 MIXTURES COMPRISING ANTHRANILIC ACID AMIDES AND ANTIDANDRUFF AGENTS AS COSMETIC AND PHARMACEUTICAL COMPOSITIONS FOR ALLEVIATING ITCHING H1-0, ASIC1, NHERF1 EPHX1 2101/4885CYP19A1 111/4885ALDH1A1 578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.